Beyond major disease-specific categories, neuroscience research relies on a shared toolkit of microglial identity proteins, astrocyte-derived biomarkers, neurogenesis markers, and synaptic scaffolding molecules. These reagents enable fundamental studies in cell-type identification, neural circuitry, synaptic plasticity, and brain injury assessment across multiple neurological conditions.
Research Use Only (RUO)Not intended for diagnostic or therapeutic procedures.
abinScience provides validated antibodies, recombinant proteins, and ELISA kits for fundamental neuroscience research targets. All products are manufactured by our parent company AtaGenix Laboratories under ISO quality systems. Browse products below or contact us for custom antibody development.
TREM2 — TREM2 is a disease-associated microglia (DAM) signature receptor and a major Alzheimer’s disease genetic risk factor. Anti-TREM2 antibodies and recombinant proteins support microglial activation profiling, phagocytosis studies, and therapeutic antibody development.
→ Browse TREM2 antibodies & proteins
S100B — S100B is an astrocyte-derived biomarker for brain injury severity in TBI, stroke, and cardiac surgery-associated neurological complications. Anti-S100B antibodies and ELISA kits support point-of-care assay development and CNS damage quantification.
→ Browse S100B antibodies & proteins
DCX (Doublecortin) — DCX is the standard marker for neuronal migration and adult neurogenesis, labeling immature migrating neurons in the hippocampal dentate gyrus and subventricular zone. Anti-DCX antibodies support neurogenesis quantification and cortical migration disorder research.
→ Browse DCX antibodies & proteins
PSD-95 (DLG4) — PSD-95 is the principal postsynaptic density scaffolding protein at excitatory synapses. Anti-PSD-95 antibodies enable synapse density quantification, excitatory/inhibitory balance analysis, and synaptic plasticity research.
→ Browse PSD-95 antibodies
Iba1 (AIF1) — Iba1 is a pan-microglial marker essential for microglial morphology analysis, activation state assessment, and density quantification by IHC/IF across neuroinflammation and neurodegeneration models.
→ Browse Iba1 antibodies & proteins
1. Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell. 2017;169(7):1276-1290. DOI
2. Michetti F, et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem. 2012;120(5):644-659. DOI
3. Gleeson JG, et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell. 1998;92(1):63-72. DOI
4. Sheng M, Kim E. The postsynaptic organization of synapses. Cold Spring Harb Perspect Biol. 2011;3(12):a005678. DOI
Human
Blocking, ELISA
Mouse
IgG1
1D7
Human, Mouse, Rat
IHC, WB
Mouse
IgG2a, kappa
N357/6
Human, Mouse, Rat
IB, ICC, IHC, IP
Mouse
IgG2a, kappa
K37/89
Human, Mouse
IF, IHC, WB
Mouse
IgG2a, kappa
N183/15
IHC, WB
Mouse
IgG2a, kappa
N68/6
IHC, WB
Mouse
IgG2a, kappa
N241A/34
IHC, WB
Mouse
IgG2a, kappa
N59/20
Human, Mouse, Rat
IHC, WB, IF
Mouse
IgG2a, kappa
N206A/8
E. coli
Q5S007
Phe1479-Pro1729
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Homo sapiens (Human)
Human
ELISA, Neutralization
Human
IgG1, kappa
9E4#